| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |